Trial intelligence / Profile preview

Effect of melatonin on prevention of delirium in hospitalized patients

IRCT2017061234482N1Phase 3Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of melatonin in delirium (2 arms), sponsored by Kermanshah University of Medical Sciences. Started Jul 2017; status: completed.

02

Drugs

melatonin
03

Conditions

delirium

Beyond the preview

Go deeper on IRCT2017061234482N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017061234482N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call